Ginkgo Bioworks Holdings, Inc. (DNA) Financials
DNA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 1.6 billion | 594.5 million |
| 2023-12-31 | 1.7 billion | 568.2 million |
| 2023-09-30 | 2.0 billion | 773.7 million |
| 2023-06-30 | 2.3 billion | 788.4 million |
DNA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | -96.0 million | 40.8 million |
| 2023-12-31 | -52.0 million | 42.8 million |
| 2023-09-30 | -77.9 million | 52.6 million |
| 2023-06-30 | -87.1 million | 61.5 million |
DNA Net Income
No data available :(
DNA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | 843.8 million | - | 234.5 million |
| 2023-12-31 | 948.9 million | - | 241.8 million |
| 2023-09-30 | 1.0 billion | - | 403.7 million |
| 2023-06-30 | 1.1 billion | - | 410.9 million |
DNA Shares Outstanding
DNA Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | 6.7 million | 123.6 million | 70.3 million | -19.3 million |
| 2023-12-31 | 3.4 million | 107.7 million | 89.2 million | -23.7 million |
| 2023-09-30 | 4.4 million | 156.7 million | 82.0 million | - |
| 2023-06-30 | 13.5 million | 144.3 million | 102.3 million | - |
DNA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | 37.9 million | 22.1 million |
| 2023-12-31 | 34.8 million | 15.9 million |
| 2023-09-30 | 55.4 million | 6.9 million |
| 2023-06-30 | 80.6 million | 18.1 million |
DNA
Price: $0.56
52 week price:
Earnings Per Share: -0.46 USD
P/E Ratio: -3.68
Exchange: NYQ
Sector: Healthcare
Industry: Biotechnology
Volume: 21.0 million
Market Capitalization: 1.9 billion